Showing 6981-6990 of 23151 results for "".
Women's Role in the Control of TB in India
https://reachmd.com/programs/clinicians-roundtable/womens-role-in-the-control-of-tb-in-india/1391/Dr. Maurice Pickard speaks with Dr. Shelly Batra, gynecologist and Medical Director for Operation Asha based in New Delhi, who expanded her vision for better women's health by confronting a well established taboo in her culture. Women are fearful about seeking medical care for tuberculosis, as thisThe Role of Genetics and Biomarketers in Treatment
https://reachmd.com/programs/clinicians-roundtable/the-role-of-genetics-and-biomarketers-in-treatment/1233/These days treatment decisions often rely on genetics and biomarkers. Are we entering the age of personalized medicine? Dr. Bruce Bloom hosts.Nail Psoriasis: Evaluating Quality-of-Life Measures and Treatment Gaps
https://reachmd.com/programs/frontlines-psoriasis/nail-psoriasis-evaluating-quality-of-life-measures-and-treatment-gaps/32440/Nail psoriasis affects a significant portion of patients with psoriasis and poses challenges that extend far beyond aesthetics. A recent review looked at patient-reported quality of life outcomes across 15 clinical trials, highlighting the disproportionate burden of nail disease, the limitations ofSurpassing the Clipboard: Integrating HIT Into Your Practice
https://reachmd.com/programs/heart-matters/surpassing-the-clipboard-integrating-hit-into-your-practice/5184/Use of electronic medical records (EMRs) and personal health records (PHRs) can improve adherence, increase efficiency and better coordinate patient care. What role are health information exchanges playing in the integration of EMRs and PHRs, and how effective are disease management software programThe New POSEIDON Criteria: The WHY, the WHAT, and the HOW
https://reachmd.com/programs/global-womens-health-academy/new-poseidon-criteria-why-what-and-how/9904/Dr. Sandro Esteves reviews the new POSEIDON criteria & discusses innovative alternatives for clinical management.Beyond Lab Values: Understanding Symptom Burden in Primary Biliary Cholangitis
https://reachmd.com/programs/gi-insights/beyond-lab-values-understanding-symptom-burden-in-primary-biliary-cholangitis/54677/Primary biliary cholangitis (PBC) is associated with a significant symptom burden that can profoundly impact patients’ quality of life. Symptoms like fatigue and pruritus are common but often underrecognized, and may persist even when laboratory findings suggest controlled disease. To explore the evQuality of Life in MacTel Type 2
https://reachmd.com/programs/cme/Quality-of-Life-in-MacTel-Type-2/35967/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.DESTINY-Breast04 Findings: T-DXd and Quality of Life in HER2-Low Metastatic Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/destiny-breast04-findings-t-dxd-and-quality-of-life-in-her2-low-metastatic-breast-cancer/36437/New insights from DESTINY-Breast04 highlight how trastuzumab deruxtecan (T-DXd) not only extends survival but also delays symptom deterioration in HER2-low metastatic breast cancer. In this AudioAbstract, Dr. Mimi Maeusli discusses key takeaways from the outcomes analysis and what they mean forEvolutionary Medicine: A New Frontier in Treating Chronic Gut Inflammation
https://reachmd.com/programs/gi-insights/evolutionary-medicine-a-new-frontier-in-treating-chronic-gut-inflammation/32329/Learn how evolution-based insights offer potential new therapeutic targets for chronic gut inflammation.Psoriasis Healthcare Barriers: Uncovering Underrepresented Patient Populations
https://reachmd.com/programs/spotlight-psoriasis/psoriasis-healthcare-barriers-uncovering-underrepresented-patient-populations/26298/What healthcare barriers are associated with patients of different ethnicities and backgrounds?